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Abstract
Background: Catheter entrapment due to severe radial artery spasm (RAS) during trans­
radial coronary catheterization has been rarely reported and its management is not precisely 
defined. The aim of this study was to determine the incidence, predictors and management of 
catheter entrapment due to severe RAS.
Methods: A total of 723 patients undergoing transradial coronary catheterization at a single 
center were retrospectively enrolled in the present study. Patients were divided into two groups: 
those with catheter entrapment due to severe RAS and those without.
Results: The incidence of catheter entrapment was 0.8%. Height (161.2 ± 9.1 cm vs. 169.6 ±  
± 10 cm, p = 0.047) and body surface area (1.86 ± 0.04 vs. 1.95 ± 0.18, p = 0.002) were 
found to be lower, and total procedure time 33.2 ± 13.4 min vs. 15.2 ± 12.3 min, p < 0.001) 
was longer in the entrapment group. Multivariate logistic regression analysis demonstrated 
that total procedure time independently predicted catheter entrapment (odds ratio: 1.057, 95% 
confidence interval [CI] 1.004–1.114, p = 0.035). Receiver-operating characteristic curve dem­
onstrated good diagnostic accuracy for prolonged total procedure time in predicting catheter 
entrapment (area under curve = 0.8, 95% CI 0.63–0.97, p = 0.01). Patients were effectively 
treated with stepwise administration of systemic vasodilators, forearm heating, sedation and 
as a last resort general anesthesia with no significant complication.
Conclusions: Catheter entrapment due to severe RAS during transradial approach was 
rare and prolonged total procedure time is an independent predictor of catheter entrapment. 
Treatment with stepwise administration of different treatment modalities is possible with no 
significant complication. (Cardiol J 2016; 23, 3: 324–332)
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Introduction
In the preceding two decades, the transradial 
approach for coronary interventions has proven to 
be safe and feasible in different clinical situations 
with a markedly decreased incidence of major 
access-site complications and early patient ambu-
lation compared to transfemoral approach [1–4].
Although radial artery has become more popu-
lar vascular access route for coronary interventions 
across the world, one of the major and well-defined 
disadvantages of the transradial approach is radial 
interventions
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artery spasm (RAS) which causes severe discom-
fort and switch to transfemoral approach [5–8]. 
Previous studies have reported the incidence, risk 
factors and management of RAS during transradial 
approach [7–10]. Severe RAS can cause the ves-
sel to clamp down on the catheter, resulting in 
catheter entrapment which causes severe pain 
while attempting to manipulate catheter. Catheter 
entrapment limits the successful completion of 
transradial catheterization and its management 
constitutes a major challenge. However, studies 
focusing on catheter entrapment due to severe 
RAS are lacking.
In this study, the authors’ aim was to inves-
tigate the incidence, predictors and management 
of catheter entrapment due to severe RAS during 
transradial coronary interventions.
Methods
Patients
A total of 723 patients undergoing transra-
dial coronary catheterization at the institution 
of Acıbadem Maslak Hospital, between October 
2013 and December 2014, were retrospectively 
enrolled into the present study. Eligible were all 
patients aged ≥ 18 years with clinical indication for 
diagnostic coronary angiography or percutaneous 
coronary intervention (PCI), in whom the right or 
left radial artery could be successfully cannulated. 
Approval of local Ethics Committee was obtained 
before starting the study, which was performed in 
accordance with the ethical standards specified in 
the Declaration of Helsinki.
Procedure
All procedures were performed by 3 interven-
tional cardiologists experienced in radial interven-
tions at a single center that performs transradial 
approach as default strategy in the cardiac cath-
eterization laboratory. Our clinic is a secondary 
center where an average of 750 coronary interven-
tions are performed annually and the percentage of 
transradial approach is about 80% of all coronary 
interventions. The right radial approach was the 
default approach for vascular access. Left radial 
artery was the preferred site in patients with pre-
vious coronary artery bypass grafting using a left 
internal mammary artery or in patients in whom 
right radial artery was occluded. Barbeau test was 
performed at baseline to confirm the presence of 
dual circulation and patency of the palmar arch [11]. 
Absence of return of the ulnar artery signal within 
2 min after cessation of compression was defined 
as an abnormal Barbeau test.
Routinely, a 6 Fr short (7 cm) hydrophilic 
sheath (Radiofocus Introducer II, Terumo, Tokyo, 
Japan) was introduced. To prevent RAS, depending 
on operator’s preference, 100–200 mg nitroglycerin 
and/or 2 mg verapamil were injected through the 
side port of the sheath. To prevent thrombosis, 
70 IU/kg unfractionated heparin was also injected 
through the side port of the sheath. Selective an-
giography of radial, brachial, or subclavian artery 
was only performed if difficulty was encountered 
during guidewire or catheter advancement. The un-
derlying cause (spasm or anatomical variation) was 
determined and at operator’s discretion, continued 
with either extra intra-arterial administration of ni-
troglycerin and/or verapamil or with primary access 
site conversion. Verapamil was not administrated in 
patients with hypotension, bradycardia, high-grade 
atrioventricular block, myocardial infarction compli-
cated with cardiogenic shock, moderate to severe 
left ventricular systolic dysfunction, or significant 
aortic stenosis. Nitroglycerin was also not admin-
istrated in patients with significant aortic stenosis, 
hypotension, or myocardial infarction complicated 
with cardiogenic shock. Sedative agents are not 
routinely used for coronary angiography, and this 
usually depends on operator’s preference.
For diagnostic procedures, a single diagnostic 
universal 5 Fr Tiger catheter (Terumo, Leuven, 
Belgium) was used. Judkins, Amplatz, multipur-
pose and pigtail 5 Fr or 6 Fr catheters were also 
used when needed. For coronary interventions, 
6 Fr Judkins, EBU, and Amplatz guiding catheters 
(Medtronic, USA) were used.
In case of planned or ad-hoc PCI, an additional 
bolus of 30 IU/kg unfractionated heparin was ad-
ministrated. Platelet glycoprotein IIb/IIIa inhibitors 
were administered as clinically indicated during 
the procedure. The radial sheath was immediately 
removed at the end of the procedure and a radial 
compression device (TR Band, Terumo, Tokyo, 
Japan) was applied at the access site.
Data collection
The clinical and angiographic data of all pa-
tients were reviewed retrospectively. Demograph-
ics of the patients and angiographic data such as 
radial artery site, total procedural time, the number 
of catheters used, administration of nitroglycerin 
and verapamil, and catheter entrapment were all 
recorded. Total procedure time was defined as the 
time interval between the initiation of the puncture 
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to the radial artery to the completion of the last 
coronary angiographic view.
Clinical definition of radial artery  
spasm and catheter entrapment
Operator-assessed RAS was determined based 
on a questionnaire addressing 5 signs:
 — persistent forearm pain;
 — pain response to catheter manipulation;
 — pain response to sheath withdrawal;
 — difficult catheter manipulation after being 
trapped by radial artery;
 — considerable resistance on withdrawal of the 
sheath.
Patients presenting with at least 2 of these 
5 signs were diagnosed as having clinical RAS [12]. 
Catheter entrapment was defined as severe lo-
cal pain associated with catheter trapping which 
restricts manipulation of catheter due to severe 
RAS [13].
Exclusion criteria
Exclusion criteria included: 1) Failure of 
sheath and/or catheters insertion into the radial 
artery due to RAS and/or severe tortuosity which 
results in transfemoral switch (n = 2); 2) Inadequte 
data collection (n = 14).
Statistical analysis
Quantitative variables were expressed as 
mean ± standard deviation, and qualitative vari-
ables were expressed as percentage (%). Data were 
tested for normal distribution using the Kolmog-
orov-Smirnov test. A comparison of parametric 
values between the two groups was made using 
a 2-tailed Student’s t-test, and for nonparametric 
values Mann-Whitney U test was used. Categori-
cal variables were compared using the c2 test or 
Fisher’s test. Binary logistic regression analysis 
was used to evaluate independent association 
between catheter entrapment and clinical param-
eters. The relationship between total procedure 
time and catheter entrapment was analyzed using 
the area under the receiver operator characteristic 
curve (AUC). A p value of < 0.05 was considered 
statistically significant. All statistical analyses 
were carried out using SPSS version 18.0 (SPSS, 
Chicago, IL, USA).
Results
The study population consisted of 723 patients 
(mean age 63 ± 10 years, range 27–90, 239 women) 
undergoing transradial coronary catheterization. 
Patients were divided into two groups; those with 
catheter entrapment (+), n = 6 (0.8%) and those 
without catheter entrapment (–), n = 716 (99.2%). 
The baseline clinical characteristics of patients 
included in the study are presented in Table 1.
Height (161.2 ± 9.1 cm vs. 169.6 ± 10 cm, p = 
= 0.047) and body surface area (1.86 ± 0.04 vs. 
1.95 ± 0.18, p = 0.002) were found to be sig-
nificantly lower in the entrapment group. Other 
baseline clinical characteristics were not different 
between the two groups (p > 0.05).
Ninety-nine percent of the study patients had 
transradial coronary catheterization via a right 
radial access. Thirty-two point six percent of the 
study patients had acute coronary syndrome, 
21.5% underwent PCI, and 8.6% had primary PCI. 
A redo transradial approach was performed in 3.9% 
of all patients. Combination of nitroglycerin and 
verapamil was administrated in 42% of the study 
patients. Diagnostic coronary angiography was 
performed using 5 Fr diagnostic catheters in 
the large majority of the patients (73.9%). Six Fr 
guiding catheters were used in all of the patients 
requiring coronary interventions. Procedural 
characteristics were similar in both groups except 
for total procedure time (33.2 ± 13.4 min vs. 15.2 ± 
± 12.3 min, p < 0.001) (Table 2).
The incidence of RAS was 14.1% (n = 102) 
and the incidence of catheter entrapment due to 
severe RAS was very low with an incidence of 0.8% 
(n = 6). Catheter entrapment was encountered in 
4 (0.7%) diagnostic procedures, and in 2 (1.3%) 
therapeutic procedures (p = 0.61). Table 3 shows 
the baseline and procedural characteristics of pa-
tients with catheter entrapment.
The effects of different variables on catheter 
entrapment were calculated in univariate analysis 
for each. The variables for which the unadjusted 
p value was £ 0.10 in logistic regression analysis 
were identified as potential risk markers and in-
cluded in the full model. Female sex, height, and 
total procedure time were analyzed with multivari-
ate logistic regression model. Multivariate logistic 
regression analysis demonstrated that total proce-
dure time independently predicted catheter entrap-
ment (odds ratio: 1.057, 95% confidence interval 
[CI]: 1.004–1.114, p = 0.035) (Table 4). Prolonged 
total procedure time was defined by total procedure 
time higher than 20.5 min, which was derived from 
receiver-operating characteristic (ROC) curve 
analysis. In the analysis of ROC curve, prolonged 
total procedure time demonstrated good diagnostic 
accuracy in predicting catheter entrapment 
(AUC = 0.8, 95% CI: 0.63–0.97, p = 0.01) (Fig. 1).
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Patients were treated with stepwise admin-
istration of systemic vasodilators, forearm heat-
ing, sedation, and, as the last resort, general 
anesthesia. As a first step treatment, systemic 
vasodilators; intravenous 2.5–5 mg verapamil, 
200–400 mg nitroglycerin or sublingual 0.4–0.8 mg 
glyceryl trinitrate were administrated to all pa-
tients with entrapment. However, none of the 
patients responded to systemic vasodilators. As 
a second step treatment, forearm heating was 
effectively applied with a convective air patient 
warming system (Warm Touch, model WT-5300 A, 
Covidien, Mansfield, USA) up to 15 min at 43°C in 
2 patients (Fig. 2). As a third step treatment, sedation 
with intravenous midazolam 1–2 mg was effective 
in 3 of the patients with persistent entrapment. 
Finally, general anesthesia was needed in a patient 
who was still unresponsive to all previous treat-
ments.
Only 1 patient with entrapment suffered from 
radial artery occlusion without hand ischemia.
Discussion
In the present study, it was shown that cath-
eter entrapment due to severe RAS during tran-
sradial approach is rare and prolonged total proce-
dure time is an independent predictor of catheter 
entrapment. Effective stepwise treatment with 
systemic vasodilators, forearm heating, sedation, 
and general anesthesia is possible with no signifi-
cant complication.
Radial artery spasm is one of the major chal-
lenges of transradial coronary interventions. Radial 
artery is particularly prone to vasospasm due to its 
muscular nature and a-adrenoceptor-predominance 
[14]. Both circulating catecholamines through acti-
vation of a1-adrenoreceptor and mechanical stimuli 
Table 1. Clinical characteristics of the study group.
Entrapment (+)  
group (n = 6)
Entrapment (–)  
group (n = 717)
P
Age [years] 56 ± 17.7 60.2 ± 10.8 0.81
Women 4 (66.7%) 235 (32.8%) 0.08
Height [cm] 161.2 ± 9.1 169.6 ± 10 0.047
Weight [kg] 82.2 ± 7.2 83.4 ± 12.6 0.81
Body surface area 1.86 ± 0.04 1.95 ± 0.18 0.002
Diabetes mellitus 2 (33.3%) 225 (31.4%) 0.99
Hypertension 3 (50%) 378 (52.7%) 0.89
Coronary artery disease 2 (33.3%) 190 (26.5%) 0.66
Smoking 1 (16.7%) 197 (27.5%) 0.99
Systolic BP [mm Hg] 117.8 ± 18.9 128.2 ± 20.6 0.22
Diastolic BP [mm Hg] 71.7 ± 11.6 75.2 ± 10.9 0.43
Heart rate [bpm] 79.8 ± 11.1 76.5 ± 14.7 0.62
Fasting glucose [mg/dL] 118.2 ± 24.9 121.4 ± 41.8 0.87
Total cholesterol [mg/dL] 214.8 ± 50.9 203.7 ± 47.7 0.64
LDL cholesterol [mg/dL] 155 ± 42.9 132.9 ± 40.3 0.28
HDL cholesterol [mg/dL] 41.3 ± 4.2 42.8 ± 13.4 0.82
Clinical presentation:
0.42
Stable angina pectoris 2 (33.3%) 376 (52.4%)
Acute coronary syndromes 2 (33.3%) 234 (32.6%)
Other conditions 2 (33.3%) 107 (14.9%)
Medications:
ACE-I 4 (66.7%) 321 (44.8%) 0.28
Beta-blocker 1 (16.7%) 303 (42.3%) 0.21
Calcium-channel blocker 2 (33.3%) 123 (17.2%) 0.28
Nitrate 0 (0%) 47 (6.60%) 0.99
ACE-I — angiotensin converting enzyme inhibitor; BP — blood pressure; HDL — high density lipoprotein; LDL — low density lipoprotein
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(sheath introduction, guidewire and catheter ma-
nipulation) cause smooth muscle cell contraction 
which results in RAS [14, 15].
Many preventive measures have been sug-
gested to prevent spasm of radial artery, such as 
sedation, adequate analgesia, hydrophilic coated 
sheaths, and intra-arterial vasodilators [7, 8, 16]. 
Various drugs have been extensively evaluated 
to prevent spasm of radial artery but there is 
currently no agreement on the optimal agents. 
Majority of previous reports advocated the use of 
intra-arterial vasodilators, most frequently vera-
pamil and/or nitrogylcerin [7, 8, 16, 17]. In a head to 
head comparison study between nitroglycerin and 
verapamil, there was no statistically significant dif-
ference in the incidence of RAS [18]. Although data 
from the SPASM trial [16] show that intra-arterial 
application of vasodilators is safe, recent data from 
the active-controlled SPasmolytic Agents to avoid 
SpasM during transradial percutaneous coronary 
interventions (SPASM3) trial [19] suggest that the 
administration of any of the tested vasodilators 
may be accompanied by adverse events. Verapamil 
is contraindicated in patients with hypotension, 
bradycardia, high-grade atrioventricular block, 
myocardial infarction complicated with cardio-
genic shock, moderate to severe left ventricular 
systolic dysfunction, or significant aortic stenosis. 
Nitroglycerin is also contraindicated in patients 
with significant aortic stenosis, hypotension, and 
cardiogenic shock. Furthermore, a recent study 
indicated that beyond the learning curve preven-
tive administration of intra-arterial verapamil offers 
no advantage over ad hoc application in terms of 
access site conversion rates [20]. In our center, in 
appropriate cases, a bolus of intra-arterial nitro-
glycerin and/or intra-arterial verapamil is given 
prophylactically.
According to previous studies, the incidence of 
RAS has varied considerably between 2% and 34% 
due to the inconsistency in prophylactic therapy 
and criteria for diagnosis [7–10]. However, severe 
RAS is less frequent and the incidence of severe 
limiting spasm resulting in femoral crossover is 
Table 2. Procedural characteristics of study group.
Entrapment (+)  
group (n = 6)
Entrapment (–)  
group (n = 717)
P
Previous transradial intervention 0 (0%) 12 (1.7%) 0.99
Radial artery site right/left 6/0 (100%/0%) 710/7 (99%/1%) 0.99
Nitroglycerine + verapamil 1 (16.7%) 303 (42.3%) 0.21
Catheter: 0.7
5 Fr diagnostic 4 (66.7%) 530 (73.9%)
6 Fr diagnostic 0 (0%) 34 (4.7%)
6 Fr guiding 2 (33.3%) 153 (21.3%)
Number of catheters used 1.3 ± 0.5 1.5 ± 0.7 0.47
Total number of catheters 0.96
1 4 (66.7%) 394 (55%)
2 2 (33.3%) 275 (38.4%)
3 0 (0%) 42 (5.9%)
4 0 (0%) 2 (0.3%)
5 0 (0%) 4 (0.6%)
Primary PCI rate 1 (16.7%) 61 (8.5%) 0.42
Total PCI rate 2 (33.3%) 154 (21.5%) 0.62
Total procedure time [min] 33.2 ± 13.4 15.2 ± 12.3 < 0.001
Following ipsilateral transradial intervention 0 (0%) 28 (3.9%) 0.99
Operators: 0.49
Operator 1 211 3
Operator 2 259 2
Operator 3 247 1
PCI — percutaneous coronary intervention
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Table 4. Effects of variables on catheter  
entrapment in univariate and multivariate  
logistic regression analyses.
Odds ratio  
(95% CI)
P
Univariate predictors
Female sex 4.102 (0.746–22.557) 0.1
Height 0.918 (0.836–1.009) 0.075
Total procedure  
time [min]
1.063 (1.023–1.105) 0.002
Multivariate predictors
Total procedure  
time [min]
1.057 (1.004–1.114) 0.035
Figure 1. Receiver operating characteristic curve analy - 
sis for prolonged total procedure time in predict-
ing catheter entrapment; AUC — area under curve; 
CI — confidence interval.
0.7% [13, 19]. In the present study, the incidence 
of RAS and severe RAS was found to be correlated 
with these previous findings and to the best of our 
knowledge, this is the first report that reveals the 
incidence of catheter entrapment due to severe 
RAS. Catheter entrapment can also be due to cathe-
ter kinking which is rare in experienced hands [21]. 
This can be prevented with avoiding over manipu-
lation of catheter. However, in the present study, 
catheter entrapment due to catheter kinking was 
not encountered.
Several RAS-associated factors have been 
identified, including patient-related factors (female 
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Ertuğrul Zencirci, Aleks Değirmencioğlu, Catheter entrapment during transradial approach
gender, young age, low body mass index, short stat-
ure, small radial artery diameter, diabetes mellitus, 
dyslipidemia, anxiety, anomalous radial artery), 
and technical factors (low radial artery to sheath 
ratio, non-hydrophilic coated sheaths, unsuccess-
ful access at first attempt, prolonged cannulation, 
multiple catheter exchanges, excessive catheter 
manipulations, limited operator experience) [8, 13, 
15–17, 22–24]. In the present study, it was dem-
onstrated that the catheter entrapment-associated 
factors were similar to these previously defined 
factors.
Several pharmacological agents have been 
proposed in the management of RAS. In case of 
severe RAS causing catheter entrapment, the use 
of intra-arterial nitroglycerin, verapamil, sublingual 
nitroglycerin, and even the use of intra-arterial 
papaverine with lidocaine have been proposed 
[8, 25]. In the present study, as a first step treatment, 
systemic vasodilators, verapamil and/or nitrates 
were administrated to all patients with entrapment.
Management of pharmacoresistant RAS caus-
ing catheter entrapment has not been precisely 
defined. Heating has been shown to be a stimulus 
evoking conduit artery dilatation. It was previously 
demonstrated that heating induces radial artery 
vasodilation through flow-mediated dilatation [26]. 
Increased local temperature has been documented 
to modulate a1-adrenergic receptor-mediated 
vasoconstriction by augmenting the release of en-
dothelial cell-derived vasodilators [27]. Nitric oxide 
and endothelium-derived hyperpolarizing factor 
are involved in flow-mediated dilatation. The pre-
sent study demonstrated that forearm heating, as 
a second step treatment, might be successful in the 
management of catheter entrapment.
Sedation with anxiolytics has been suggested 
as a means to reduce the incidence of spasm as 
vasospasm can be triggered by procedure-related 
anxiety and pain [8]. Recently, low doses of an 
opioid/benzodiazepine (fentanyl/midazolam) com-
bination has been reported to be associated with 
a substantial reduction in the rate of RAS [28]. 
Besides the sedative and analgesic action, ben-
zodiazepines also have direct vasoactive effects. 
Midazolam was shown to induce vasodilation and 
attenuate the vasoconstrictive response to adren-
ergic stimuli [29]. Thereby midazolam might have 
a role in the prevention and reversal of vasospasm 
in the setting of adrenergic overactivation situ-
ations, such as cardiac catheterization-related 
stress. In the present study, sedation with intra-
venous midazolam as a third step treatment was 
effective in patients with catheter entrapment. 
Thus, sedation with intravenous midazolam in 
conjunction with other treatments can be effective 
in case of catheter entrapment.
In case of persistent catheter entrapment due 
to resistant severe RAS despite all the treatments, 
general anesthesia can be an effective last resort 
strategy as in the case of the present study [8, 30]. 
General anesthesia attenuates neurogenic influ-
ences contributing to RAS.
The present study suggested a management 
strategy of catheter entrapment with stepwise 
administration of different treatment modalities. 
The algorithm is outlined in Figure 3.
Limitations of the study
The most important limitations of the present 
study were that it was retrospective and conducted 
Figure 2. Forearm heating with a convective air pa-
tient warming system (Warm Touch, model WT-5300 A, 
Covidien, Mansfield, USA) in a patient with catheter 
entrapment.
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in a single, moderate-volume institution. The 
incidence of catheter entrapment due to severe 
RAS was extremely low and this might cause the 
predictors of catheter entrapment to be less reli-
able. Further prospective studies are warranted to 
confirm the findings of the present study. Routine 
forearm angiography was not performed in order 
to determine radial artery anomaly. In the manage-
ment of catheter entrapment, administration of 
incremental doses of intravenous midazolam was 
not applied and intravenous midazolam dosage 
is limited to 1–2 mg, which may not be enough 
for some patients. Another limitation may be the 
absence of routine pre-procedural sedation, which 
has been well proven to reduce the incidence of 
radial spasm. The present study did not report the 
post-procedural complications like hemorrhage or 
radial artery occlusion, the focus of the study was 
to describe the incidence, predictors and manage-
ment of catheter entrapment due to severe RAS.
Conclusions
Catheter entrapment due to severe RAS dur-
ing transradial approach was rare and prolonged 
total procedure time is an independent predictor 
of catheter entrapment. Treatment with stepwise 
administration of different treatment modalities is 
possible with no significant complications.
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